首页 > 市场调查报告书 > 製药

妇科治疗

市场调查报告书

商品编码

1741249

雌激素阻断剂市场：依产品类型、应用、通路和地区划分

Estrogen Blockers Market, By Product Type, By Application, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

雌激素阻断剂市场规模预计在 2025 年达到 170.4 亿美元，预计到 2032 年将达到 264.8 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.5%。

分析范围		分析详细信息
基准年	2024	市场规模（2025年）	170.4亿美元
效能数据	2020-2024	预测期	2025-2032
预测期内的复合年增长率（2025-2032）	6.50%	预计金额（2032年）	264.8亿美元

雌激素阻断剂是FTM（女变男）患者在荷尔蒙补充疗法（HRT）中用来抑制体内雌激素作用的药物。它们也能促进男性第二性征的发展。雌激素阻断剂种类繁多，有些效果较佳。

雌激素阻断剂可以锭剂或註射剂形式服用。它们通常作为更大规模HRT治疗方案的一部分开具，患者通常耐受性良好。在大多数情况下，服用这些药物不需要住院，通常可以在家中服用。

市场动态

雌激素阻断剂主要用于治疗荷尔蒙相关疾病，如卵巢症候群（PCOS）、子宫内膜异位症、乳癌等。随着这些疾病在国际上的盛行率增加，对雌激素阻断剂的需求也在上升，刺激了市场扩张。

例如，根据世界卫生组织（WHO）2023年6月28日发布的报告，卵巢症候群（PCOS）是一个重大的公共卫生问题，被认为是影响育龄妇女最常见的荷尔蒙失调之一。据估计，该疾病每年影响8-13%的育龄妇女，高达70%的病例未被诊断出来。

然而，与任何药物一样，雌激素阻断剂也存在潜在的风险和副作用。潮热、忧郁、关节不适和胆固醇升高是一些典型的副作用。在某些情况下，长期使用雌激素阻断剂可能会增加心血管疾病和骨质疏鬆的风险。安全性问题和潜在的副作用可能会影响患者对雌激素阻断剂的依从性和接受度。

本报告的主要特点

本报告对全球雌激素阻断剂市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
它还强调了每个细分市场的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
全球雌激素阻断剂市场的主要企业是根据以下参数列出的，例如公司概况、产品系列、主要亮点、财务表现和策略。
透过本报告的见解，负责人和企业经营团队可以就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
「全球雌激素阻断剂市场」报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过用于分析全球雌激素阻断剂市场的各种策略矩阵来更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 17.04 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 26.48 Bn

Estrogen blockers are medicines that are used by FTM (female to male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of estrogen blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

For instance, on June 28, 2023, according to a report published by the World Health Organization, reported that polycystic ovary syndrome (PCOS) is a significant public health problem and considered as one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age every year, and up to 70% of cases are undiagnosed.

On the other hand, like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term use of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:

This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global estrogen blockers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Olema Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Allorion Therapeutics Inc, Carrick Therapeutics Limited, Criterium, Inc. and Hoffmann-La Roche
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market

Detailed Segmentation:

Global Estrogen Blockers Market, By Product Type:
- Selective Estrogen Receptor Modulators (SERMs)
- Aromatase Inhibitors
- Estrogen Receptor Downregulators (ERDs)
- Others
Global Estrogen Blockers Market, By Application:
- Breast Cancer Treatment
- Hormone Replacement Therapy (HRT)
- Infertility Treatment
- Post-Menopausal Osteoporosis
- Others
Global Estrogen Blockers Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Estrogen Blockers Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Pfizer Inc.
- Novartis AG
- AstraZeneca PLC
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol Myers Squibb Company
- Sanofi S.A.
- AbbVie Inc.
- GlaxoSmithKline plc
- Olema Pharmaceuticals, Inc.
- Scorpion Therapeutics, Inc.
- Allorion Therapeutics Inc
- Carrick Therapeutics Limited
- Criterium, Inc.
- F.Hoffmann-La Roche

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Estrogen Blockers, By Product Type
- Market Estrogen Blockers, By Application
- Market Estrogen Blockers, By Distribution Channel
- Market Estrogen Blockers, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Hormone-related Disorders
- Restraints
Side Effects and Safety Concerns
- Opportunities
Expansion of Indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Estrogen Blockers Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Selective Estrogen Receptor Modulators (SERMs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Aromatase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Estrogen Receptor Downregulators (ERDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Estrogen Blockers Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Breast Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hormone Replacement Therapy (HRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Infertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Post-Menopausal Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Estrogen Blockers Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Estrogen Blockers Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bristol Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Olema Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Scorpion Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Allorion Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Carrick Therapeutics Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Criterium, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

雌激素阻断剂市场：依产品类型、应用、通路和地区划分

Estrogen Blockers Market, By Product Type, By Application, By Distribution Channel, By Geography

市场动态

本报告的主要特点

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

4. 全球雌激素阻断剂市场：COVID-19感染疾病的影响

5. 全球雌激素阻断剂市场（依产品类型）（2020-2032）

6. 全球雌激素阻断剂市场应用（2020-2032）

7. 全球雌激素阻断剂市场依通路划分（2020-2032）

8. 全球雌激素阻断剂市场（按地区）（2020-2032）

第九章竞争态势

第 10 章章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Estrogen Blockers Market, By Product Type, 2020-2032, (US$ Bn)

6. Global Estrogen Blockers Market, By Application, 2020-2032, (US$ Bn)

7. Global Estrogen Blockers Market, By Distribution Channel, 2020-2032, (US$ Bn)

8. Global Estrogen Blockers Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

雌激素阻断剂市场：依产品类型、应用、通路和地区划分

Estrogen Blockers Market, By Product Type, By Application, By Distribution Channel, By Geography

市场动态

本报告的主要特点

目录

第一章 调查目的与前提条件

第二章 市场展望

第三章市场动态、法规与趋势分析

4. 全球雌激素阻断剂市场：COVID-19感染疾病的影响

5. 全球雌激素阻断剂市场（依产品类型）（2020-2032）

6. 全球雌激素阻断剂市场应用（2020-2032）

7. 全球雌激素阻断剂市场依通路划分（2020-2032）

8. 全球雌激素阻断剂市场（按地区） （2020-2032）

第九章 竞争态势

第 10 章 章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Estrogen Blockers Market, By Product Type, 2020-2032, (US$ Bn)

6. Global Estrogen Blockers Market, By Application, 2020-2032, (US$ Bn)

7. Global Estrogen Blockers Market, By Distribution Channel, 2020-2032, (US$ Bn)

8. Global Estrogen Blockers Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

第一章调查目的与前提条件

第二章市场展望

8. 全球雌激素阻断剂市场（按地区）（2020-2032）

第九章竞争态势

第 10 章章节